The effect of PHOSPHate control On Renal function in chronic kidney disease patients not on dialysis
- Conditions
- hyperphosphatemia chronic kidney disease (CKD)
- Registration Number
- JPRN-UMIN000025161
- Lead Sponsor
- Department of Internal medicine, Teikyo University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 160
Not provided
1. Administration contraindication of ferric citrate 2. History of hypersensitivity to ferric citrate 3. Iron excess such as hemochromatosis 4. Uncontrolled diabetes mellitus; HbA1c >=9.0 % (NGSP) 5. Uncontrolled hypertension; systolic blood pressure >=170 mmHg or diastolic blood pressure >=110 mmHg 6. Acute renal failure, nephrotic syndrome, dialysis, or renal transplantation 7. Complication or history of malignant tumor (not excluded from the study when the malignant tumor is not treated within 5 years and if there is no recurrence) 8. Pregnancy, nursing, or planned pregnancy during the study 9. Hormone replacement therapy with estrogens during the study 10. Intake of activated vitamin D or cinacalcet at the confirmation of eligibility 11. Ineligibility at the investigator's discretion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method